BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 7872779)

  • 21. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
    Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
    Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase.
    Swinney DC; Webb AS; Freedman R
    Biochem Pharmacol; 1991 Nov; 42(12):2341-9. PubMed ID: 1662512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid discrimination and omega-hydroxylation by cytochrome P450 4A1 and a cytochrome P4504A1/NADPH-P450 reductase fusion protein.
    Alterman MA; Chaurasia CS; Lu P; Hardwick JP; Hanzlik RP
    Arch Biochem Biophys; 1995 Jul; 320(2):289-96. PubMed ID: 7625836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A transgenic mouse expressing human CYP4B1 in the liver.
    Imaoka S; Hayashi K; Hiroi T; Yabusaki Y; Kamataki T; Funae Y
    Biochem Biophys Res Commun; 2001 Jun; 284(3):757-62. PubMed ID: 11396967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
    Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The regiospecific hydroxylation of lauric acid by rainbow trout (Oncorhynchus mykiss) cytochrome P450s.
    Buhler DR; Miranda CL; Deinzer ML; Griffin DA; Henderson MC
    Drug Metab Dispos; 1997 Oct; 25(10):1176-83. PubMed ID: 9321521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3.
    Helvig C; Dishman E; Capdevila JH
    Biochemistry; 1998 Sep; 37(36):12546-58. PubMed ID: 9730827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The induction of cytochrome P450 isoform, CYP4A1, by clofibrate coincides with activation of ethanolamine-specific phospholipid base exchange reaction in rat liver microsomes.
    Lenart J; Komańska I; Jasińska R; Pikuła S
    Acta Biochim Pol; 1998; 45(1):119-26. PubMed ID: 9701504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxylation of lauramide diethanolamine by liver microsomes.
    Merdink J; Decosta K; Mathews JM; Jones CB; Okita JR; Okita RT
    Drug Metab Dispos; 1996 Feb; 24(2):180-6. PubMed ID: 8742229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene B4 omega-hydroxylase in rat liver microsomes: identification as a cytochrome P-450 that catalyzes prostaglandin A1 omega-hydroxylation, and participation of cytochrome b5.
    Sumimoto H; Kusunose E; Gotoh Y; Kusunose M; Minakami S
    J Biochem; 1990 Aug; 108(2):215-21. PubMed ID: 2172223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique properties of purified, Escherichia coli-expressed constitutive cytochrome P4504A5.
    Hosny G; Roman LJ; Mostafa MH; Masters BS
    Arch Biochem Biophys; 1999 Jun; 366(2):199-206. PubMed ID: 10356284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
    Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
    J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol consumption enhances fatty acid omega-oxidation, with a greater increase in male than in female rats.
    Ma X; Baraona E; Lieber CS
    Hepatology; 1993 Nov; 18(5):1247-53. PubMed ID: 8225232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes.
    Okita RT; Masters BS
    Drug Metab Dispos; 1980; 8(3):147-51. PubMed ID: 6104577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
    Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ
    Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
    Parikh A; Guengerich FP
    Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1.
    Faulkner KM; Shet MS; Fisher CW; Estabrook RW
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7705-9. PubMed ID: 7644480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole.
    Dierks EA; Davis SC; Ortiz de Montellano PR
    Biochemistry; 1998 Feb; 37(7):1839-47. PubMed ID: 9485309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.